State Street Corp Kal Vista Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,093,643 shares of KALV stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,093,643

Previous 1,390,863 21.37%

Holding current value

$17.5 Million

Previous $11.8 Million 7.13%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$7.4 - $12.6 $2.2 Million - $3.74 Million	-297,220 Reduced 21.37%	1,093,643 $12.6 Million
Q4 2024 Feb 14, 2025	BUY	$8.09 - $12.5 $964,764 - $1.49 Million	119,254 Added 9.38%	1,390,863 $11.8 Million
Q3 2024 Nov 14, 2024	BUY	$9.46 - $15.39 $4.87 Million - $7.93 Million	515,179 Added 68.11%	1,271,609 $14.7 Million
Q2 2024 Aug 14, 2024	BUY	$10.35 - $12.49 $1.68 Million - $2.03 Million	162,257 Added 27.31%	756,430 $8.91 Million
Q1 2024 May 15, 2024	BUY	$11.07 - $16.04 $631,775 - $915,418	57,071 Added 10.63%	594,173 $7.05 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $589,390 - $952,511	77,756 Added 16.93%	537,102 $6.58 Million
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $117,880 - $149,490	13,171 Added 2.95%	459,346 $4.42 Million
Q2 2023 Aug 14, 2023	BUY	$7.73 - $10.57 $208,045 - $284,480	26,914 Added 6.42%	446,175 $4.02 Million
Q1 2023 May 15, 2023	BUY	$6.3 - $8.39 $96,396 - $128,375	15,301 Added 3.79%	419,261 $3.3 Million
Q4 2022 Feb 14, 2023	SELL	$4.2 - $14.24 $75,007 - $254,312	-17,859 Reduced 4.23%	403,960 $2.73 Million
Q3 2022 Nov 15, 2022	BUY	$9.85 - $16.83 $113,934 - $194,672	11,567 Added 2.82%	421,819 $6.12 Million
Q2 2022 Aug 15, 2022	SELL	$8.16 - $15.1 $4.31 Million - $7.98 Million	-528,615 Reduced 56.3%	410,252 $4.04 Million
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $1.27 Million - $1.92 Million	-113,109 Reduced 10.75%	938,867 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $100,709 - $148,945	8,148 Added 0.78%	1,051,976 $13.9 Million
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $6.1 Million - $8.73 Million	-356,673 Reduced 25.47%	1,043,828 $18.2 Million
Q2 2021 Aug 16, 2021	BUY	$23.12 - $29.91 $18.7 Million - $24.2 Million	809,029 Added 136.78%	1,400,501 $33.6 Million
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $4.76 Million - $13.8 Million	323,818 Added 120.98%	591,472 $15.2 Million
Q4 2020 Feb 16, 2021	BUY	$12.88 - $19.47 $91,306 - $138,022	7,089 Added 2.72%	267,654 $5.08 Million
Q3 2020 Nov 10, 2020	BUY	$9.83 - $13.99 $86,454 - $123,042	8,795 Added 3.49%	260,565 $3.28 Million
Q2 2020 Aug 14, 2020	BUY	$6.75 - $12.89 $45,690 - $87,252	6,769 Added 2.76%	251,770 $3.05 Million
Q1 2020 May 11, 2020	BUY	$5.8 - $18.56 $1.42 Million - $4.55 Million	245,001 New	245,001 $1.87 Million

Others Institutions Holding KALV

# of Institutions

141

Shares Held

54.4M

Call Options Held

1.38M

Put Options Held

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $394M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Kal Vista Pharmaceuticals, Inc. Transaction History